Versiti Blood Research Institute, Milwaukee, Wisconsin, USA.
Division of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
J Thromb Haemost. 2022 Jul;20(7):1576-1588. doi: 10.1111/jth.15713. Epub 2022 Apr 6.
Type 3 von Willebrand Disease (VWD) is a rare and severe form of VWD characterized by the absence of von Willebrand factor (VWF).
As part of the Zimmerman Program, we sought to explore the molecular pathogenesis, correlate bleeding phenotype and severity, and determine the inheritance pattern found in type 3 VWD families.
PATIENTS/METHODS: 62 index cases with a pre-existing diagnosis of type 3 VWD were analyzed. Central testing included FVIII, VWF:Ag, VWF:RCo, and VWFpp. Bleeding symptoms were quantified using the ISTH bleeding score. Genetic analysis included VWF sequencing, comparative genomic hybridization and predictive computational programs.
75% of subjects (46) had central testing confirming type 3, while 25% were re-classified as type 1-Severe or type 1C. Candidate VWF variants were found in all subjects with 93% of expected alleles identified. The majority were null alleles including frameshift, nonsense, splice site, and large deletions, while 13% were missense variants. Additional studies on 119 family members, including 69 obligate carriers, revealed a wide range of heterogeneity in VWF levels and bleeding scores, even amongst those with the same variant. Co-dominant inheritance was present in 51% of families and recessive in 21%, however 28% were ambiguous.
This report represents a large cohort of VWD families in the U.S. with extensive phenotypic and genotypic data. While co-dominant inheritance was seen in approximately 50% of families, this study highlights the complexity of VWF genetics due to the heterogeneity found in both VWF levels and bleeding tendencies amongst families with type 3 VWD.
3 型血管性血友病(VWD)是一种罕见且严重的 VWD 形式,其特征是缺乏血管性血友病因子(VWF)。
作为 Zimmerman 计划的一部分,我们试图探讨 3 型 VWD 家族的分子发病机制、出血表型和严重程度的相关性,并确定其遗传模式。
患者/方法:分析了 62 例先前诊断为 3 型 VWD 的指数病例。中心检测包括 FVIII、VWF:Ag、VWF:RCo 和 VWFpp。使用 ISTH 出血评分量化出血症状。遗传分析包括 VWF 测序、比较基因组杂交和预测计算程序。
75%的受试者(46 例)的中心检测结果证实为 3 型,而 25%的受试者重新分类为 1 型-重度或 1 型 C 型。所有受试者均发现候选 VWF 变体,93%的预期等位基因均被鉴定。大多数为无义、移码、剪接位点和大片段缺失的无效等位基因,而 13%为错义变体。对 119 名家族成员(包括 69 名必然携带者)的进一步研究显示,VWF 水平和出血评分存在广泛的异质性,即使是在具有相同变体的个体中也是如此。51%的家族存在共显性遗传,21%为隐性遗传,但 28%的家族遗传方式不明确。
本报告代表了美国一个大型的 VWD 家族队列,具有广泛的表型和基因型数据。虽然在大约 50%的家族中观察到共显性遗传,但本研究强调了 VWF 遗传的复杂性,因为在 3 型 VWD 家族中,VWF 水平和出血倾向存在异质性。